Recent trends of Japanese hepatocellular carcinoma due to HCV in aging society

Hepatogastroenterology. 2012 Sep;59(118):1893-5. doi: 10.5754/hge11732.

Abstract

Background/aims: The mean age of hepatocellular carcinoma (HCC) patients has increased (=65 years old). We want to identify the recent trend of the clinical features of HCC patients due to hepatitis C virus (HCV) (HCV-HCC).

Methodology: From 2000 to 2009, 855 naive HCC patients were admitted. HCV-HCC patients were divided into two groups, first period group (2000-04, n=270) and second period group (2005-09, n=343) and the clinical features of HCV-HCC were investigated.

Results: There was no difference in gender, TNM stage and percentages of HCV-HCC between the periods. On the other hand, the ratio of HCV-HCC patients with worse liver function (Child-Pugh B or C), elderly (=75 years old) and the population of patients treated with low invasive radiofrequency ablation were increased (30.0% to 42.0%, 17.2% to 35.8% and 25.1% to 36.2%, respectively; p<0.01). The 1y-, 3y- and 5y-survival rate of HCV-HCC did not show differences (82.1%, 60.5% and 44.7% vs. 81.8%, 56.9% and 37.7%, respectively; p=0.219).

Conclusions: The ratio of aged HCV-HCC as well as HCV-HCC patients with worse liver function was increased. The less invasive treatment for HCC in these patients and the quick anti-viral treatment for HCV patients should be considered to avoid occurrence of HCC in Japan.

MeSH terms

  • Age Factors
  • Aged
  • Aging*
  • Antiviral Agents / therapeutic use
  • Asian People* / statistics & numerical data
  • Carcinoma, Hepatocellular / ethnology
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / therapy
  • Carcinoma, Hepatocellular / virology*
  • Chi-Square Distribution
  • Disease Progression
  • Female
  • Hepatitis C / complications*
  • Hepatitis C / drug therapy
  • Hepatitis C / ethnology
  • Humans
  • Incidence
  • Japan / epidemiology
  • Liver Neoplasms / ethnology
  • Liver Neoplasms / pathology
  • Liver Neoplasms / therapy
  • Liver Neoplasms / virology*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Survival Analysis
  • Time Factors

Substances

  • Antiviral Agents